|
Mechanismfactor Xa inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. |
First Approval Date18 May 2011 |
100 Clinical Results associated with Bristol-Myers Squibb/Pfizer EEIG
0 Patents (Medical) associated with Bristol-Myers Squibb/Pfizer EEIG
100 Deals associated with Bristol-Myers Squibb/Pfizer EEIG
100 Translational Medicine associated with Bristol-Myers Squibb/Pfizer EEIG